|
12th Congress of the European Hematology Association
|
|
|
|
Dr. G. Kato
|
| Search Tips: here are some examples |
| Abdominal obesity | Returns slides that contain AT LEAST ONE of the words |
| +Abdominal +obesity | Returns slides with BOTH words |
| +Abdominal -obesity | Returns slides with Abdominal ONLY and eliminates all slides with obesity |
| Cardio* | Returns slides with Cardio, Cardiology, Cardiovascular, etc. |
| "Abdominal obesity" | Returns only slides with this EXACT COMBINATION and order of words |
|
|
|
|
|
Bethesda, United States of America 
National Heart- Lung- and Blood Institute
Dr. Kato is currently the director of the Sickle Cell Vascular Disease Unit in the Vascular Medicine Branch of the National Heart, Lung and Blood Institute, and an investigator in the Critical Care Medicine Department at the NIH Clinical Center. He is board certified in pediatric hematology-oncology, and serves as part-time faculty at the Johns Hopkins University School of Medicine and attending physician at Howard University Hospital. His current research focuses on understanding mechanisms of vascular complications of sickle cell disease, especially pulmonary hypertension, and finding new therapeutic approaches for this vasculopathy. His work focuses on markers and mediators of endothelial dysfunction in sickle cell disease, particularly those that affect nitric oxide homeostasis.
|
|
| Presentations by Dr. G. Kato currently available on MultiWebcast.com |
12th Congress of the European Hematology Association
|
|
|
|
|
